Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
3
|
| pubmed:dateCreated |
1981-10-25
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Mar
|
| pubmed:issn |
0014-2964
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
17
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
365-6
|
| pubmed:dateRevised |
2009-11-11
|
| pubmed:meshHeading |
pubmed-meshheading:6167447-Aged,
pubmed-meshheading:6167447-Bleomycin,
pubmed-meshheading:6167447-Drug Interactions,
pubmed-meshheading:6167447-Humans,
pubmed-meshheading:6167447-Methotrexate,
pubmed-meshheading:6167447-Middle Aged,
pubmed-meshheading:6167447-Pelvic Neoplasms,
pubmed-meshheading:6167447-Vincristine
|
| pubmed:year |
1981
|
| pubmed:articleTitle |
Vincristine and bleomycin do not interfere with infusional plasma levels of methotrexate.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|